Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   
Ascendis Health Ltd.  –  JSE:ASC  
     
Prices at least 15 minutes delayed. Source: JSE Ltd.
 
Watch ASC 
 
 
Zoom: 
1D 2D 3M 1Y 3Y 5Y 10Y
JSE Overall 92 763 0.29%
Pharma & Biotech 11 919 0.02%
 
More performance data
10 Day Trading Range
0.80 0.87
Peer Comparison
ASPEN (APN)119.32 (0.15%)
ADCOCK (AIP)49.26 (-2.26%)
ASCENDIS (ASC)0.83 (1.22%)
NUMERAL (XII)0.01 (0.00%)
Customise
Analysts' positions on ASC
Detailed forecasts
Visual Calendar for ASC
ASC Calendar Table
Institutional Support for ASC
Mar 2025 quarter -1.75%
Dec 2024 quarter -85.56%
Unit Trust Holdings
Sector: Pharmaceuticals and Biotechnology
 
ASC  Latest Market Data
Yesterday's Close0.82   P/E Ratio30.37
Today's Open0.83   EPS - TTM 2.70
Best Bid0.84 x 64 332   DPS - TTM Dividend 11
Best Offer0.87 x 41 453   Dividend Yield
Volume 104 377   Market Cap 524.95m
Day's Range0.83–0.85   Shares In Issue 632.47m
Detailed quote
Latest SENS Latest News
Latest Results for ASC
6 months ended Dec 2024 (published Mar 2025) Interim
(ZAR million)%chgDec 24 Dec 23R
Turnover-- 737.6
Attributable Income-49.3% 40.3 79.5
Market Cap (ZARm)28.2% 626.0 488.3
EPS (ZARc)-49.6% 6.40 12.70
HEPS (Cont Ops)(ZARc)455.6% 5.00 0.90
DPS (ZARc)---
View Comment Detailed financials
 
Nature of Business
Ascendis Health is a health and wellness investment holding company marketing and distributing a portfolio of leading brands, products and medical devices.
Company Factsheet
 
 
Portfolio  
Watch List  
Recently viewed


 
 
* Price data source: JSE Ltd. All other statistics calculated by ProfileData.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2025  ]
  


Powered by ProfileData


Follow us on: